Decitabine assists umbilical cord-derived mesenchymal stem cells in improving glucose homeostasis by modulating macrophage polarization in type 2 diabetic mice
Abstract Background Mesenchymal stem cells (MSCs) have emerged as a promising therapy for type 2 diabetes (T2D). Mechanistic researches demonstrate that the anti-diabetic effect of MSCs is partially mediated by eliciting macrophages into an anti-inflammatory phenotype thus alleviating insulin resist...
Main Authors: | Jieqing Gao, Yu Cheng, Haojie Hao, Yaqi Yin, Jing Xue, Qi Zhang, Lin Li, Jiejie Liu, Zongyan Xie, Songyan Yu, Bing Li, Weidong Han, Yiming Mu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-08-01
|
Series: | Stem Cell Research & Therapy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13287-019-1338-2 |
Similar Items
-
Low-Dose Decitabine Assists Human Umbilical Cord-Derived Mesenchymal Stem Cells in Protecting β Cells via the Modulation of the Macrophage Phenotype in Type 2 Diabetic Mice
by: Jing Xue, et al.
Published: (2020-01-01) -
Low-dose decitabine priming with intermediate-dose cytarabine followed by umbilical cord blood infusion as consolidation therapy for elderly patients with acute myeloid leukemia: a phase II single-arm study
by: Xiaoyang Li, et al.
Published: (2019-08-01) -
Effective treatment of low-dose decitabine in myelodysplastic syndrome/myeloproliferative neoplasms
by: Ye X, et al.
Published: (2017-11-01) -
Effects of Decitabine on the proliferation of K562 cells and the expression of DR4 gene
by: Wenhui Zhang, et al.
Published: (2018-02-01) -
Acute appendicitis in acute leukemia and the potential role of decitabine in the critically ill patient
by: Deepti Warad, et al.
Published: (2015-01-01)